Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Novel effects of statins in enhancing efficacy of chemotherapy in vitro in nasopharyngeal carcinoma. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1016/s0140-6736(05)66698-6
10.1016/s0140-6736(05)66698-6 · External reference
Nasopharyngeal carcinoma: molecular biomarker discovery and progress
10.1186/1476-4598-6-1 · 2007 · External reference
10.3322/canjclin.55.2.74
10.3322/canjclin.55.2.74 · External reference
10.1038/nrc1452
10.1038/nrc1452 · External reference
10.1016/j.ijrobp.2005.06.037
10.1016/j.ijrobp.2005.06.037 · External reference
10.1016/j.ijrobp.2006.06.013
10.1016/j.ijrobp.2006.06.013 · External reference
10.2165/00003088-199732050-00005
10.2165/00003088-199732050-00005 · External reference
10.1007/s00392-004-0081-5
10.1007/s00392-004-0081-5 · External reference
10.1182/blood-2006-09-048033
10.1182/blood-2006-09-048033 · External reference
10.1111/j.1349-7006.2007.00471.x
10.1111/j.1349-7006.2007.00471.x · External reference
10.1093/carcin/bgi036
10.1093/carcin/bgi036 · External reference
Activation of programmed cell death by anticancer agents: cisplatin as a model system
1990 · External reference
10.1074/jbc.m400732200
10.1074/jbc.m400732200 · External reference
10.1007/s00280-008-0830-7
10.1007/s00280-008-0830-7 · External reference
10.1002/pros.21131
10.1002/pros.21131 · External reference
10.1111/j.1572-0241.2007.01773.x
10.1111/j.1572-0241.2007.01773.x · External reference
10.1128/jvi.79.21.13326-13337.2005
10.1128/jvi.79.21.13326-13337.2005 · External reference
Inhibition of Ras farnesylation by lovastatin leads to down‐regulation of proliferation and migrating in primary cultured human glioblastoma cells
2000 · External reference
Inhibition of cell growth by lovastatin is independent of ras function
1991 · External reference
10.1046/j.1471-4159.1998.70062397.x
10.1046/j.1471-4159.1998.70062397.x · External reference
10.1046/j.1365-2141.1998.00783.x
10.1046/j.1365-2141.1998.00783.x · External reference
10.1038/sj.onc.1202792
10.1038/sj.onc.1202792 · External reference
10.1093/carcin/22.8.1139
10.1093/carcin/22.8.1139 · External reference
10.1016/j.ijrobp.2005.05.061
10.1016/j.ijrobp.2005.05.061 · External reference
10.1016/s0360-3016(03)00117-2
10.1016/s0360-3016(03)00117-2 · External reference
10.1172/jci0216421
10.1172/jci0216421 · External reference
10.1080/10623320303360
10.1080/10623320303360 · External reference
10.1158/0008-5472.can-07-5807
10.1158/0008-5472.can-07-5807 · External reference
10.1161/01.res.0000202706.70992.95
10.1161/01.res.0000202706.70992.95 · External reference
Improved biochemical outcomes with statin use in patients with high‐risk localized prostate cancer treated with radiotherapy
External reference
10.1016/j.atherosclerosis.2007.07.031
10.1016/j.atherosclerosis.2007.07.031 · External reference
10.4049/jimmunol.181.5.3524
10.4049/jimmunol.181.5.3524 · External reference
10.1074/jbc.m505268200
10.1074/jbc.m505268200 · External reference
10.1046/j.1523-1755.2003.00744.x
10.1046/j.1523-1755.2003.00744.x · External reference
10.1111/j.1365-2249.2010.04170.x
10.1111/j.1365-2249.2010.04170.x · External reference
